Literature DB >> 2404479

Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature.

M Lishner1, R G Perrin, R Feld, H A Messner, P G Tuffnell, T Elhakim, A Matlow, J E Curtis.   

Abstract

The complications associated with the use of Ommaya reservoirs in 106 patients with meningeal involvement due to malignant disease are reviewed. Twenty-seven patients had acute lymphoblastic leukemia, 12 acute myelogenous leukemia, 3 chronic lymphocytic leukemia, 34 lymphoma, 29 carcinoma, and 1 chronic myelocytic leukemia. There were 11 technical complications, including 1 death due to misplacement of the catheter, 2 mild intraventricular hemorrhages, and 5 malfunctioning reservoirs; 3 required craniotomies (1 for subdural hematoma and 2 for subdural hygroma); 13 cases of bacterial meningitis occurred in 10 patients. One patient died of Staphylococcus aureus meningitis. The organisms causing the other infections were mainly coagulase-negative staphylococci (8 cases) or Propionibacterium acnes (2 cases). The projected infection rate for all patients (by Kaplan-Meier analysis) during the first year following insertion of a reservoir was 15%. Successful use of Ommaya reservoirs requires expert surgical implantation and meticulous care during accessing to minimize complications.

Entities:  

Mesh:

Year:  1990        PMID: 2404479

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  25 in total

Review 1.  Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.

Authors:  Stacey L Berg; Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 2.  The Use of Ommaya Reservoirs to Deliver Central Nervous System-Directed Chemotherapy in Childhood Acute Lymphoblastic Leukaemia.

Authors:  Ruairi Wilson; Caroline Osborne; Christina Halsey
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

3.  Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication.

Authors:  L K Norris; S A Grossman; A Olivi
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

4.  Exteriorisation of the Ommaya Reservoir Secondary to Wound Dehiscence in a Case of ALL.

Authors:  Uday Yanamandra; Eshita Raju; Rajan Kapoor; Suman Pramanik; Ankur Ahuja; Tathagata Chatterjee; Satyaranjan Das
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-05       Impact factor: 0.900

Review 5.  Current options for the treatment of neoplastic meningitis.

Authors:  Ilkcan Cokgor; Allan H Friedman; Henry S Friedman
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

Review 6.  Pneumocephalus due to nasopharyngeal carcinoma: case report.

Authors:  M C Kiu; Y L Wan; S H Ng; S T Lee; S P Hao
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

7.  Troubleshooting an unusual complication following intrathecal chemotherapy delivered via Ommaya catheter: A case report.

Authors:  David J Mauler; Kent R Richter; Sarah Merrill; Cristina Valencia-Sánchez; Chandan Krishna; Maciej M Mrugala
Journal:  Mol Clin Oncol       Date:  2020-04-22

8.  Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.

Authors:  Fahed Zairi; Emilie Le Rhun; Nicolas Bertrand; Thomas Boulanger; Sophie Taillibert; Rabih Aboukais; Richard Assaker; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2015-06-13       Impact factor: 4.130

9.  Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.

Authors:  R de Waal; P R Algra; J J Heimans; J G Wolbers; P Scheltens
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

Review 10.  Toxicity of treatment for neoplastic meningitis.

Authors:  Tali Siegal
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.